(Q41739207)

8 October 2017

Regulation of TCR-induced IFN-gamma release from islet-reactive non-obese diabetic CD8(+) T cells by prostaglandin E(2) receptor signaling (English)

1 reference

8 October 2017

0 references

Ganapathy V

1

1 reference

8 October 2017

Gurlo T

series ordinal

2

1 reference

8 October 2017

Jarstadmarken HO

series ordinal

3

1 reference

8 October 2017

von Grafenstein H

series ordinal

4

1 reference

8 October 2017

1 June 2000

1 reference

8 October 2017

International Immunology

1 reference

8 October 2017

12

1 reference

8 October 2017

851-860

1 reference

8 October 2017

6

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.6.851

8 October 2017

1 reference

Autoimmune diabetes: how many steps for one disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.6.851

An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.6.851

The APC1 concept of type I diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.6.851

Differential modulation of T helper type 1 (Th1) and T helper type 2 (Th2) cytokine secretion by prostaglandin E2 critically depends on interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.6.851

PGE2 inhibits IL-2 and IL-4-dependent proliferation of CTLL-2 and HT2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.6.851

Prostaglandin E receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.6.851

Prostaglandin E2 and other cyclic AMP elevating agents inhibit interleukin 2 gene transcription by counteracting calcineurin-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.6.851

Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.6.851

Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.6.851

Identification of 19 (R)-OH prostaglandin E2 as a selective prostanoid EP2-receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.6.851

T cell activation determined by T cell receptor number and tunable thresholds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.6.851

Prostanoid receptors. Structure, function, and distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.6.851

Checkpoints in the progression of autoimmune disease: lessons from diabetes models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.6.851

Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.6.851

Prostaglandin E2 selectively increases interferon gamma receptor expression on human CD8+ lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.6.851

Prostaglandin E2 enhancement of interferon-gamma production by antigen-stimulated type 1 helper T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.6.851

58 Rapid extraction of arachidonic acid metabolites from biological samples using octadecylsilyl silica

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F12.6.851

21 January 2018

Identifiers

DOI

10.1093/INTIMM/12.6.851

1 reference

8 October 2017

1 reference